3/18
02:46 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/18
08:43 am
vrtx
Vertex Pharmaceuticals (VRTX) was upgraded by Maxim Group from "hold" to "buy". They now have a $575.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) was upgraded by Maxim Group from "hold" to "buy". They now have a $575.00 price target on the stock.
3/18
07:51 am
vrtx
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
Medium
Report
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
3/10
12:11 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
12:11 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
10:36 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
10:36 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
10:32 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
10:32 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
09:48 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
09:48 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
3/10
06:12 am
vrtx
Vertex Pharmaceuticals initiated with a Buy at Jefferies
Low
Report
Vertex Pharmaceuticals initiated with a Buy at Jefferies
3/10
06:12 am
vrtx
Vertex Pharmaceuticals initiated with a Buy at Jefferies
Low
Report
Vertex Pharmaceuticals initiated with a Buy at Jefferies
2/17
10:56 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/17
10:48 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/17
10:48 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/17
07:01 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/13
02:19 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
02:19 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
01:05 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/13
01:05 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/13
12:52 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
12:52 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
12:15 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
2/13
11:12 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.